EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced its consolidated revenues for the third quarter and nine months ended September 30, 2015. € millions Sept. 30, 2015 9 months Sept 30, 2014
All News
FARMINGDALE, N.Y., Oct. 21, 2015 /PRNewswire/ — Misonix, Inc. (NASDAQ: MSON), an international ultrasonic surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery, wound and burn care, and other surgical specialties, successfully introduced the new BoneScalpel MIS
By Anuja Vaidya Ziehm Imaging and the Navigation Division of Stryker have signed a co-marketing agreement. Here are four key notes: 1. As per the agreement, Stryker Navigation will promote Ziehm’s Vision RFD 3D C-arm for neurosurgical, spinal, orthopedic and trauma surgeries. READ
By Megan Wood Ohio State researchers are creating customized spine models to reflect patients’ specific anatomies, according to OSU.edu. Here are five highlights: 1. Ehud Mendel, MD, and William Marras, PhD, are combining their medicine and engineering expertise to produce personalized
By Laura Dyrda The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold. Here are five key notes: 1. The study will now include 10 patients instead of the original five patients. READ MORE HERE
By Laura Dyrda A new study presented at the 30th Annual North American Spine Society meeting challenges conventional wisdom about the optimal long posterior cervical spine fusion length. The single-center retrospective study covered 105 adult patients …
CDN$550,000 Advance on Biotech Firm’s Path to Becoming Publicly Traded Company SCOTTSDALE, AZ–(Marketwired – October 16, 2015) – Lattice Biologics Inc. is pleased to announce that Blackstone Ventures Inc. (TSX VENTURE: BLV), a company listed on the TSX Venture Exchange, has received funding of CDN$1.37
By Megan Wood The non-fusion spinal devices market is expected to continue growing through 2025, according to a Future Market Insights report. Here are five points: 1. An aging population, rising number of obese patients and increasing demand for minim…
EAST PROVIDENCE, RI–(Marketwired – Oct 19, 2015) – IlluminOss Medical a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, will be exhibiting its groundbreaking IlluminOss System at the German Congress of Orthopaedics and Traumatology (DKOU) 2015 in Hall 2.2 Booth #43. IlluminOss’ minimally invasive technology uniquely
NEW YORK, Oct. 19, 2015 /PRNewswire/ — Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1